The Characteristics of Cardiovascular Adverse Events in Therapy With Immune Checkpoint Inhibitors: The Result of Work of the Multi-Disciplinary Team. Вопр. онкол. 2024, 70 (3), 541-549. https://doi.org/10.37469/0507-3758-2024-70-3-541-549.